4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-24-009596
CHIEF MEDICAL OFFICER sold 9,000 shares at $29.50 ($265,500)
- CHIEF MEDICAL OFFICER acquired 9,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gillies Hunter CHIEF MEDICAL OFFICER | 2024-03-28 | Option exercise 10b5-1 | +9,000 | $2.14 | $19,260 | 12,251 | D |
| Gillies Hunter CHIEF MEDICAL OFFICER | 2024-03-28 | Sale 10b5-1 | −9,000 | $29.50 | $265,500 | 3,251 | D |
| Derivatives | |||||||
| Gillies Hunter CHIEF MEDICAL OFFICER | 2024-03-28 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,000 | 89,510 | D | ||
| Open-market sales · 9,000 sh · avg $29.50 · $265,500 | |||||||
Loading xslF345X05/form4-04012024_060401.xml…